#United States #Dallas #Exchange Offers #Kimberly-Clark #Kenvue Notes

Kimberly-Clark Completes Kenvue Notes Exchange Offers

Kimberly-Clark Corporation, known for its leading health and wellness products, has recently finalized its offers to exchange outstanding Kenvue notes for new Kimberly-Clark notes. This announcement, made on November 3, 2026, signals a significant milestone for the company as it navigates the complexities of corporate finance.

The Exchange Offers aimed to swap up to $7 billion of Kenvue LLC’s notes for Kimberly-Clark’s new notes, alongside cash payments and related consent solicitations. These offers, aimed at holders of Kenvue Notes, expired on November 2, 2026, and the results indicate a robust engagement from investors in the financial markets.

Key Figures from the Exchange Offers

As of the expiration date, significant amounts of Kenvue Notes were validly tendered. Here’s a brief overview:

• - 5.050% Senior Notes due 2028:

- Outstanding Amount: $1 billion
- Tendered: $739,347,000 (73.93%)

• - 5.000% Senior Notes due 2030:

- Outstanding Amount: $1 billion
- Tendered: $846,989,000 (84.70%)

• - 4.850% Senior Notes due 2032:

- Outstanding Amount: $750 million
- Tendered: $702,706,000 (93.69%)

• - 4.900% Senior Notes due 2033:

- Outstanding Amount: $1.25 billion
- Tendered: $1,152,617,000 (92.21%)

• - 5.100% Senior Notes due 2043:

- Outstanding Amount: $750 million
- Tendered: $728,377,000 (97.12%)

• - 5.050% Senior Notes due 2053:

- Outstanding Amount: $1.5 billion
- Tendered: $1,478,073,000 (98.54%)

• - 5.200% Senior Notes due 2063:

- Outstanding Amount: $750 million
- Tendered: $727,930,000 (97.06%)

This robust response highlights investor confidence in Kimberly-Clark’s fiscal strategy and the overall health of the company’s operations.

Upcoming Settlement Details

The company anticipates that settlement of these Exchange Offers will occur on November 4, 2026, bringing forth new Kimberly-Clark notes issued in exchange for the validly tendered Kenvue notes. Each series of Kimberly-Clark notes will match the corresponding interest rates and maturity dates of the Kenvue notes, further ensuring a seamless transition for the noteholders.

Eligible holders who participated prior to the early participation date were entitled to receive an extra early participation premium alongside the new Kimberly-Clark notes. This premium not only incentivizes early participation but also signifies the company’s commitment to rewarding its investors.

Compliance and Regulatory Landscape

It’s noteworthy that the Kimberly-Clark notes offered through this exchange have not been registered under U.S. securities laws, indicating a strategic approach to limited public exposure. Unlike typical public offerings, these exchanges were conducted under strict eligibility criteria, targeting qualified institutional buyers within compliant frameworks of U.S. securities regulations.

Conclusion

Kimberly-Clark’s successful navigation of the Kenvue notes exchange offers not only underlines its operational agility but also showcases its robust relationships with investors. As the company continues to thrive with its consumer health and personal care brands globally, this event marks another chapter in its efforts to maintain financial strength and investor interest. With Kimberly-Clark's commitment to sustainable practices and shareholder returns, this recent maneuver is poised to enhance its market position and operational capabilities going forward.